Priyanka Kasnavia

Priyanka Kasnavia is an online marketing specialist who has been working at Simmons and Fletcher, P.C., for over a year. She graduated from Texas Christian University in 2017 with a degree in Strategic Communication and has been accepted to the University of Houston Law Center starting fall of 2018. Priyanka's expertise centers on search engine optimization and content creation.

All Posts By Priyanka Kasnavia

Valsartan Recall News

Since July 2018, the FDA has been investigating negative side effects associated with pharmaceuticals containing the active ingredient valsartan. Their investigation began with a voluntary recall which was issued in response to the finding of the carcinogen N-nitrosodimethylamine (NDMA). A carcinogen is a substance or exposure that can lead to cancer. In September, the FDA […]

Houston Traffic Apps

Resources for Houston Drivers With over 2 million people living in the City of Houston, it is no surprise that traffic can become overly congested very quickly. Whether it is construction, bad weather or reckless drivers, if there is heavy traffic on the road, there is a way for you to know about it. Below […]

Proton Pump Inhibitor Lawsuit Update

Ongoing Proton Pump Inhibitor Litigation In June 2018, the plaintiff’s counsel for the ongoing Proton Pump Inhibitor (PPI) MDL No. 2789 tolled the statue of limitations, give them more time to investigate the factual basis of PPI kidney injury claims. The details of the agreement can be found in the official court filing, linked above. […]

289 Million Dollar Verdict in Roundup Lawsuit

Plaintiff in First Roundup Lawsuit Verdict Awarded $289 Million On August 10, 2018, the first Roundup lawsuit filed against Monsanto concluded when a San Francisco jury awarded plaintiff Dewayne Johnson $289 million in damages. Dewayne Johnson filed a lawsuit against the biotechnical manufacturer after developing non-Hodgkin’s lymphoma as a result of prolonged exposure to a […]

Zostavax Manufacturer Faces Litigation Over Shingles Vaccine

In July 2018, Zostavax manufacturer, Merck & Co., Merick Sharp & Dhome Corp., and McKesson Corp., were named in a lawsuit filed by 100 individuals in a Superior Court of New Jersey. Plaintiffs in this lawsuit are alleging that the manufacturer acted negligently when it came to warning consumers and their healthcare providers of the […]

Important Considerations for Getting a Car

Is It Better to Buy or Lease a Car? There are many important considerations associated with buying or leasing a vehicle. From monthly payments to mileage limits, the decision of whether or not to lease a car can only truly be answered by the individual making the financial commitment. When evaluating the factors associated with […]

Roundup Lawsuit Update

Roundup Weed Killer Litigation On June 18, 2018, the first Roundup lawsuit involving Monsanto, a multinational agricultural biotechnology corporation, began in a San Francisco District Court. There are approximately 4,000 lawsuits filed against Monsanto by users who developed non-Hodgkin’s lymphoma after prolonged exposure to the popular herbicide, Roundup. More than 400 of these Roundup lawsuits […]

French Chemical Company Indicted in Texas

Harris County Grand Jury Indicts Arkema for Crosby Plant Explosion On Friday August 3, a Harris County grand jury indicted French chemical company Arkema, and 2 officials, for a “reckless” chemical release that resulted in a chemical plant explosion during Hurricane Harvey. After sustaining almost seven-feet of floodwater, the plant lost power did not have […]

Houston Vulnerable Road User Ordinance

Vulnerable Road Users in Houston According to a preliminary report conducted by the Governors Highway Safety Association, there were nearly 6,000 pedestrians killed in motor vehicle crashes in 2017. Unfortunately, car accidents involving pedestrians seem to be more common; however, there are other road users who are also at a disadvantage when it comes to […]

Essure Birth Control Device Update

Bayer Announces Removal of Essure from Marketing Starting 2019 On Friday, medical device manufacturer, Bayer announced that beginning December 31, 2018, they will no longer sell the controversial Essure birth control device in the United States. Bayer announced that its decision to discontinue Essure, “is based on a decline in U.S. sales of Essure in […]